TITLE

Goserelin 10.8 mg, 3.6 mg had similar safety, efficacy

PUB. DATE
October 2008
SOURCE
Hem/Onc Today;10/25/2008, Vol. 9 Issue 19, p17
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on a study in Japan, which showed that goserelin 10.8 milligrams (mg) three-month depot was as safe and effective as goserelin 3.6 mg monthly depot in premenopausal women with breast cancer. The results of the study, sponsored by AstraZeneca, were presented by Hiroji Iwata, chief of breast surgery at Aichi Cancer Center Hospital, at the 2008 Breast Cancer Symposium.
ACCESSION #
34781533

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics